name nAnno nOverlap fc zscore pvalue adjp or CIl CIu
path:hsa04724 Glutamatergic synapse 114 6 8.53 6.39 6.2e-05 0.0026 10.3 3.47 25.5
path:hsa04713 Circadian entrainment 96 5 8.44 5.79 0.00028 0.0032 9.93 2.97 26.2
path:hsa04750 Inflammatory mediator regulation of TRP channels 97 5 8.35 5.75 3e-04 0.0032 9.82 2.94 25.9
path:hsa04723 Retrograde endocannabinoid signaling 148 6 6.57 5.4 0.00026 0.0032 7.79 2.64 19.1
path:hsa04730 Long-term depression 60 4 10.8 6.01 0.00047 0.0041 12.6 3.16 36.9
path:hsa04720 Long-term potentiation 67 4 9.67 5.62 0.00072 0.0052 11.2 2.82 32.6
path:hsa04068 FoxO signaling pathway 131 5 6.19 4.72 0.0012 0.0072 7.13 2.15 18.7
path:hsa04540 Gap junction 88 4 7.37 4.74 0.002 0.0097 8.38 2.12 24.1
path:hsa05414 Dilated cardiomyopathy 89 4 7.28 4.7 0.0021 0.0097 8.28 2.1 23.8
path:hsa05032 Morphine addiction 91 4 7.12 4.63 0.0023 0.0097 8.09 2.05 23.3
path:hsa04915 Estrogen signaling pathway 98 4 6.61 4.41 0.003 0.011 7.48 1.9 21.4
path:hsa04022 cGMP-PKG signaling pathway 163 5 4.97 4.04 0.0031 0.011 5.66 1.71 14.7
path:hsa04923 Regulation of lipolysis in adipocytes 54 3 9 4.65 0.0044 0.014 10.1 1.94 33.6
path:hsa04725 Cholinergic synapse 112 4 5.79 4.03 0.0048 0.014 6.5 1.65 18.5
path:hsa04020 Calcium signaling pathway 181 5 4.48 3.74 0.0048 0.014 5.07 1.53 13.2
path:hsa04213 Longevity regulating pathway - multiple species 62 3 7.84 4.26 0.0064 0.017 8.75 1.68 28.8
path:hsa04924 Renin secretion 65 3 7.48 4.14 0.0073 0.017 8.32 1.6 27.3
path:hsa04024 cAMP signaling pathway 198 5 4.09 3.48 0.007 0.017 4.61 1.4 12
path:hsa04728 Dopaminergic synapse 130 4 4.99 3.62 0.0081 0.018 5.55 1.42 15.8
path:hsa04261 Adrenergic signaling in cardiomyocytes 144 4 4.5 3.35 0.012 0.025 4.99 1.27 14.2
path:hsa05410 Hypertrophic cardiomyopathy (HCM) 83 3 5.86 3.51 0.014 0.028 6.43 1.24 20.9
path:hsa04921 Oxytocin signaling pathway 152 4 4.26 3.21 0.014 0.028 4.71 1.2 13.4
path:hsa04211 Longevity regulating pathway 89 3 5.46 3.34 0.017 0.032 5.98 1.16 19.4
path:hsa04970 Salivary secretion 90 3 5.4 3.31 0.018 0.032 5.91 1.15 19.2
path:hsa04912 GnRH signaling pathway 92 3 5.28 3.26 0.019 0.032 5.77 1.12 18.7
path:hsa01522 Endocrine resistance 95 3 5.12 3.18 0.02 0.032 5.58 1.08 18.1
path:hsa04914 Progesterone-mediated oocyte maturation 96 3 5.06 3.16 0.021 0.032 5.52 1.07 17.9
path:hsa04972 Pancreatic secretion 96 3 5.06 3.16 0.021 0.032 5.52 1.07 17.9
path:hsa04916 Melanogenesis 101 3 4.81 3.04 0.024 0.034 5.24 1.02 16.9
path:hsa05142 Chagas disease (American trypanosomiasis) 102 3 4.77 3.02 0.025 0.034 5.18 1.01 16.8
path:hsa05202 Transcriptional misregulation in cancer 179 4 3.62 2.8 0.024 0.034 3.97 1.02 11.2
path:hsa04659 Th17 cell differentiation 107 3 4.54 2.91 0.028 0.036 4.93 0.959 15.9
path:hsa04080 Neuroactive ligand-receptor interaction 277 5 2.93 2.58 0.027 0.036 3.23 0.982 8.35
path:hsa04919 Thyroid hormone signaling pathway 116 3 4.19 2.73 0.034 0.043 4.53 0.882 14.6
path:hsa04071 Sphingolipid signaling pathway 118 3 4.12 2.69 0.036 0.044 4.45 0.867 14.4
path:hsa04611 Platelet activation 123 3 3.95 2.6 0.04 0.046 4.26 0.831 13.7
path:hsa04015 Rap1 signaling pathway 210 4 3.09 2.42 0.039 0.046 3.36 0.861 9.47
path:hsa04380 Osteoclast differentiation 127 3 3.83 2.54 0.043 0.049 4.12 0.804 13.3
